2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research
P Gaba, BJ Gersh, J Muller, J Narula… - Nature Reviews …, 2023 - nature.com
Understanding the natural history of coronary artery atherosclerosis is necessary to
determine prognosis and prescribe effective therapies. Traditional management of coronary …
determine prognosis and prescribe effective therapies. Traditional management of coronary …
Long-term evolocumab in patients with established atherosclerotic cardiovascular disease
ML O'Donoghue, RP Giugliano, SD Wiviott, D Atar… - Circulation, 2022 - Am Heart Assoc
Background: In FOURIER (Further Cardiovascular Outcomes Research With PCSK9
Inhibition in Subjects With Elevated Risk), the proprotein convertase subtilisin-kexin type 9 …
Inhibition in Subjects With Elevated Risk), the proprotein convertase subtilisin-kexin type 9 …
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive …
Background Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate
atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to …
atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to …
《 2021 ACC/AHA/SCAI 冠状动脉血运重建指南》 解读.
任李， 张定国 - Journal of Practical Electrocardiology, 2022 - search.ebscohost.com
美国心脏病学会(ACC), 美国心脏协会(AHA), 心血管造影和介入学会(society for cardiovascular
angiography and interventions, SCAI) 2021 年12 月联合发布了新版冠状动脉(简称冠脉) …
angiography and interventions, SCAI) 2021 年12 月联合发布了新版冠状动脉(简称冠脉) …
Inflammation in acute myocardial infarction: the good, the bad and the ugly
Convergent experimental and clinical evidence have established the pathophysiological
importance of pro-inflammatory pathways in coronary artery disease. Notably, the interest in …
importance of pro-inflammatory pathways in coronary artery disease. Notably, the interest in …
2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular …
Writing Committee, DM Lloyd-Jones, PB Morris… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Alirocumab and coronary atherosclerosis in asymptomatic patients with familial hypercholesterolemia: the ARCHITECT study
L Pérez de Isla, JL Díaz-Díaz, MJ Romero… - Circulation, 2023 - Am Heart Assoc
Background: The effect of alirocumab, a PCSK9 (proprotein convertase subtilisin/kexin type
9) inhibitor, on coronary plaque burden in patients with familial hypercholesterolemia has …
9) inhibitor, on coronary plaque burden in patients with familial hypercholesterolemia has …
PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis
X Wang, D Wen, Y Chen, L Ma, C You - Cardiovascular diabetology, 2022 - Springer
Abstract Background The Food and Drug Administration has approved Proprotein
Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors for the treatment of dyslipidemia …
Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors for the treatment of dyslipidemia …
[HTML][HTML] There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and …
ME Makover, MD Shapiro, PP Toth - American Journal of Preventive …, 2022 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) is epidemic throughout the world and is
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …